Earnings Estimates

Glossary »

Stock Information

Price (Prev Close) 1,310.00
Price - 52 Week High 1,489.00
Price - 52 Week Low 970.00
Price Date (Latest) Aug 22, 2017
Median Price Target 1,487.50
Diff from Prev Close 177.50
% Difference 13.55%

Reference Information

Last Actual (FY0) 19.22
FY0 End Date Dec '16
Indicated Annual Div. N/A
Hist (5 Yr) Growth % 68.63 %
Hist (5 Yr) Stability % 177.00 %
Yield (%) N/A

 

Analyst Forecasts

Last Month Revisions
Fiscal Period Mean High Low Median # of Estimates # Up # Down Mean % Change
Annual
Dec '19
52.13 94.10 36.57 50.56 14 3 1 -3.79 %
Annual
Dec '18
33.03 45.60 22.10 31.69 13 3 8 -1.55 %
Annual
Dec '17
17.71 22.11 13.80 17.52 14 0 11 -12.50 %
Quarterly
Sep '17
2.91 5.15 0.70 2.90 4 0 2 29.44 %
Quarterly
Dec '17
7.45 10.11 3.91 7.90 4 0 2 -26.59 %
Quarterly
Mar '18
0.00 0.00 0.00 0.00 1 0 0 N/A
Long Term Growth
N/A
34.47 45.70 22.30 34.95 4 2 1 0.14 %

 

Actuals

Fiscal Period Reported EPS Mean Estimates Surprise % Change
Annual
Dec '16
19.22 15.79 21.70 %
Quarterly
Sep '16
3.06 1.11 175.18 %
Quarterly
Dec '16
13.62 7.36 85.12 %
Quarterly
Mar '17
0.26 -0.19 240.54 %
Quarterly
Jun '17
4.95 7.03 -29.57 %
Annual
Dec '15
12.56 11.26 11.54 %
Annual
Dec '14
5.26 4.05 29.88 %

 

P/E Ratios

Genmab A/S - eafe hea multi-industry

Fiscal Period Genmab A/S eafe hea multi-industry Industry Relative
FY0 68.16 57.39 1.19
FY1 73.99 62.30 1.19
FY2 39.66 33.39 1.19

 

EPS Growth Rates

Genmab A/S - eafe hea multi-industry

Growth Rates Genmab A/S eafe hea multi-industry Industry Relative
FY1/FY0 -7.88 -7.88 1.00
FY2/FY1 86.57 86.57 1.00
FY3/FY2 57.81 57.81 1.00

Disclaimer: Mean earnings estimates are calculated by First Call based on their earnings projections made by the analysts who cover Genmab A/S. Please note that any opinions, estimates or forecasts regarding Genmab A/S's performance made by these analysts (and therefore the average estimate numbers) are theirs and do not represent opinions, forecasts or predictions of Genmab A/S or its management. Genmab A/S does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Prices are in DKK